This is a StreetInsider.com Premium Only Page

(CYBN) – Globe Newswire

Sep 27, 2022 07:30 AM Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Apr 29, 2022 08:35 AM KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing

Apr 25, 2022 08:35 AM KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th

Mar 7, 2022 08:30 AM Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leads Out in Psychedelic-Based Therapeutics Space

Mar 3, 2022 08:30 AM Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Unleashing Power of Psychedelics

Jun 28, 2021 08:35 AM Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Jun 23, 2021 08:35 AM Cybin to Present at the Life Sciences Investor Forum on June 24th

Jun 21, 2021 08:35 AM Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021

Jun 21, 2021 07:00 AM CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference on June 23. Register Now

Mar 26, 2021 08:30 AM Cybin Inc. (NEO: CYBN) at Forefront of Psychedelic Revolution

Mar 25, 2021 08:30 AM Cybin Inc. (NEO: CYBN) in Prime Position as Interest in Psychedelic Medicine Surges

Jan 11, 2021 12:19 PM Emerging Markets Report: A Time to Grow

Dec 18, 2020 08:30 AM Cybin Inc. (NEO: CYBN) Looking to Solve Long-Standing Problem with MDD Treatment

Dec 17, 2020 08:30 AM Cybin Inc. (NEO: CYBN) Acquisition, Three-Pillar Approach Reason for Optimistic MDD Outlook

Dec 14, 2020 08:06 AM CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings

Nov 13, 2020 08:30 AM New Study Finds Psychedelic Treatments More Effective than Typical Antidepressant Medications

Nov 11, 2020 08:30 AM New Therapeutic Protocols Targeting Debilitating Disorders on the Horizon